Erfonrilimab is a humanized single-domain bispecific antibody-Fc fusion protein (VH-VH-h-CH2-CH3 dimer) targeting the immune checkpoints PD-L1 and CTLA-4.
Purity:
>99.0%
CAS Number:
[2367013-69-0]
* VAT and and shipping costs not included. Errors and price changes excepted
